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Introduction 
Dermatofibromas (DF) are benign histiocytic tumors 
whose pathogenesis is not totally understood [1]. 
They usually present as one or a few 
hyperpigmented papules or nodules on the limbs, 
with no associated symptoms [2]. The occurrence of 
multiple DF is rare and has been reported mainly in 
association with autoimmune diseases, states of 
immunosuppression, and some systemic therapies 
[3]. We report a woman who developed multiple 
dermatofibromas in association with pregnancy. 
 
Case Synopsis 
We report a 40-year-old woman with an 
unremarkable past medical history, who was referred 
to our dermatology clinic because of the appearance 
of multiple asymptomatic papules and nodules over 
a period of one month. She denied taking any 
medication and there were no other associated 
symptoms. Physical examination revealed nine 
hyperpigmented dermal papules and nodules, with 
sizes ranging between 2 and 8mm (Figure 1). The 
“dimple sign” was observed when lateral pressure 
was applied to the lesions. Dermoscopy revealed a 
faint pigmented network surrounding a pale central 
amorphous area (Figure 2). Three of the lesions were 
excised and histopathologic examination revealed a 
proliferation of fibrohistiocytic cells in the upper half 
of the dermis, with presence of a Grenz zone, 
epidermal hyperplasia, and hyperpigmentation of 
the basal cell layer (Figure 3). 
The diagnosis of multiple dermatofibromas was 
made based on the findings of clinical, dermoscopic, 
and histopathological examinations. Laboratory 
tests were conducted to rule out an associated 
systemic condition. Complete blood cell count and 
general biochemistry and thyroid function studies 
showed normal results. Serologies for human 
immunodeficiency virus, hepatitis B and C, anti-
Abstract 
Dermatofibromas are common and asymptomatic 
benign histiocytic tumors. The occurrence in a small 
number (up to 5 lesions) is frequent. However, the 
expression “multiple eruptive dermatofibromas” is 
reserved for the appearance of more than 5 lesions in 
less than four months. Multiple eruptive 
dermatofibromas are rare and usually associated 
with an underlying systemic condition, the most 
common being autoimmune diseases or HIV 
infection. Herein we report multiple eruptive 
dermatofibromas developing in an otherwise 
healthy pregnant woman. Although the 
pathogenesis of this condition remains unknown, it is 
believed to be related to immunological alterations, 
given the strong association with states of 
immunosuppression or, in the case of pregnancy, 
with a state of immunotolerance. 
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nuclear antibodies, and double-stranded DNA 
antibodies were all negative. 
Two weeks after the first evaluation, the patient 
returned to the hospital complaining of supra-pubic 
pain. A gynecological ultrasound was performed, 
revealing a gestational sac with an embryo aged 6 
weeks and 6 days. The patient remained under close 
follow-up and some new lesions appeared during 
the rest of the pregnancy. After delivery, all the 
lesions remained stable and no new ones have 
developed in the following 6 months. 
 
Case Discussion 
Dermatofibromas or benign fibrous histiocytomas 
are dermal growths usually presenting as 
hyperpigmented papules or nodules with no 
associated symptoms [3]. They are more common in 
women between the third and fifth decade of life 
and usually arise on the legs [4-6]. The precise 
mechanism for the development of DF is not 
currently known. They may represent a neoplastic 
process (as demonstrated by its clonal proliferative 
growth and no spontaneous regression) or a reactive 
tissue change (secondary to trauma after an insect 
bite or prior folliculitis), [7, 8]. 
The diagnosis of DF is usually based on clinical and 
dermoscopic findings, but the only way of 
confirming it is by histopathology. On microscopic 
examination, DF are dermal tumors characterized by 
a proliferation of fibrohistiocytic cells with an 
overlying “Grenz” zone of sparing, without mitosis or 
necrosis. There is also entrapment of collagen at the 
periphery of the lesion and the overlying epidermis 
may be acanthotic with increased basal layer 
pigmentation. Immunohistochemistry staining for 
factor XIIIa is usually positive [1, 6]. This is a marker of 
fibrohistiocytic proliferation, usually positive in 
dermal dendrocytes and useful to differentiate 
dermatofibrosarcoma protuberans from 
dermatofibroma. In general, these lesions require no 
treatment apart from reassurance. 
The presence of one or a few DF is common, as 
opposed to the appearance of multiple lesions over 
a short period of time. This variant, called multiple 
eruptive dermatofibromas (MEDF), was first 
described in 1970 [9] and is usually defined as the 
appearance of 5 to 8 DF within a period of four 
months [10]. MEDF are estimated to occur in less 
Figure 1. Dermatofibromas. Multiple hyperpigmented papules 
and nodules distributes all over the skin surface. 
Figure 2. Dermoscopy of a dermatofibroma showing a faint 
pigmented network surrounding a pale central area.
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than 1% of patients with DF [11] and are associated 
with an underlying systemic condition in at least 
two-thirds of the cases [12-14]. In 80% of the cases, 
this underlying condition is related to some 
immunologic disturbance [12]. 
In this sense, the most frequent associations are with 
autoimmune diseases (namely systemic lupus 
erythematosus, dermatomyositis, or Sjögren 
syndrome), states characterized by immune-
suppression (either immunosuppressive 
medications or HIV infection) and hematologic 
malignancies [3]. Other reported underlying 
conditions include pulmonary hypertension, atopic 
dermatitis, Down syndrome, and hypertri-
glyceridemia [3]. 
To the best of our knowledge, the association of 
MEDF with pregnancy has been reported only in one 
patient [15]. This was a 25-year-old woman who 
presented four months postpartum complaining of 
the development of multiple pigmented skin lesions 
during her preceding pregnancy. The lesions were 
asymptomatic and the diagnosis of 
dermatofibromas was confirmed by histopathologic 
examination. Treatment with cryotherapy was 
performed and the patient remained well and with 
no new lesions after 17 months of follow-up [15]. 
The aforementioned association between MEDF and 
immune-mediated diseases or states of  
immunosuppression strongly suggests that immune 
mechanisms may be involved in the development of 
this condition [16]. In fact, it has been proposed that 
MEDF may represent an abortive immunoreactive 
process mediated by dermal dendritic cells in the 
setting of an inhibition of down-regulatory T cells 
[16]. In other words, it is possible that in the genesis 
of MEDF a putative antigen is involved, which cannot 
be cleared from the skin by the suppressed immune 
system, leading to the development of these 
characteristic skin lesions [17]. In this way, MEDF 
have been described as a possible manifestation of a 
subjacent condition associated with 
immunosuppression [12]. 
Pregnancy has traditionally been considered “the 
greatest paradox of all the laws of tissue 
transplantation,” as a human fetal allograft survives 
and growths in a potentially hostile immunological 
environment [15]. Indeed, it is known that pregnancy 
is associated with a state of materno-fetal tolerance 
comprising several mechanisms, which are just 
beginning to be understood. In this field, increasing 
attention is recently being given to the importance 
of regulatory T cells [18]. According to this immune 
mechanism, the development of MEDF in the setting 
of pregnancy can be considered as a manifestation 
of this altered immunity.  
Figure 3. Dermatofibroma. A) Histopathologic examination showing a non-encapsulated nodule that occupies the upper half of the 
dermis. B) This nodule is mainly composed of spindle cells, with entrapment of collagen fibers. H&E, A) 40×, B) 400×. 
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Conclusion 
Multiple eruptive dermatofibromas are rare but may 
be the first manifestation of several underlying 
conditions. Although its pathogenesis has not been 
completely elucidated, it is believed that impaired 
immune function plays an important role in their 
development. In any patient presenting with MEDF, 
it is important to search for associated conditions or  
underlying diseases. Systemic lupus erythematosus 
and HIV infection should be sought in patients 
presenting with MEDF. In women, pregnancy should 
also be assessed. 
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